ALDR - Alder BioPharma Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 AAPL (0.49%) AYX (1.77%) TTOO (4.63%) ATOM (5.44%) AMRN (0%) AAL (0.27%) SBE (6.27%) PINS (3.42%) OSTK (1.32%) ONE (-5%) NBRV (2.85%) MSFT (0.64%) KBNT (19.88%) JMIA (-1.92%) IWM (0.43%) IDXX (1.74%) FVRR (1.19%) FTCH (0.1%) FHN (-1.55%) FE (0.61%) FB (0.81%) ETSY (10.66%) EEM (0.95%) CZR (1.06%) CRM (0.33%)

ALDR - Alder BioPharmaceuti...

$18.88 0[0%]

15 mins delayed data

People also watch : LLY | RDUS | JNJ | ABBV | BMY | PFE

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close		Open
Volume		Market Cap	913.22M
Yield		Last Dividend

Day

52 Week

All You Need to Know About Alder BioPhar...	10/15/19
Alder BioPharmaceuticals (ALDR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank ...

The Daily Biotech Pulse: Acceleron Shelv...	09/17/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 16)...

Danish Company To Buy Migraine Drug Deve...	09/16/19
Merger Monday dawned with Danish pharma company Lundbeck announcing a definitive agreement to buy U.S.-based Alder Biopharmaceuticals Inc (NASDAQ: ALD...

The Daily Biotech Pulse: EC Nod For Bris...	08/28/19
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 27) ...

The Daily Biotech Pulse: Sanofi's Dupixe...	08/06/19
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks No biotech stocks hit 52-week highs Monday. Down I...

Alder Biopharmaceuticals Sees Hammer Cha...	07/19/19
Alder Biopharmaceuticals, Inc. (ALDR) has been struggling lately, but the selling pressure may be coming to an end soon.

Alder BioPharmaceuticals?? Presents New ...	05/08/19
- Data presented at the 2019 American Academy of Neurology (AAN) meeting demonstrate nearly 60% of patients reported very much or much improvement in ...

Alder BioPharmaceuticals, Inc. (ALDR) Q1...	05/02/19
ALDR earnings call for the period ending March 31, 2019.

Alder Biopharmaceuticals, Inc. (ALDR) CE...	05/02/19
Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR) Q1 2019 Earnings Conference Call May 02, 2019, 17:00 ET Company Participants Michael Horowicz - Stern Inv...

U.S. Food and Drug Administration Accept...	04/22/19
BOTHELL, Wash., April 22, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing n...

Alder Biopharmaceuticals CEO: Spreading ...	04/05/19
Jim Cramer chats with Alder Biopharmaceuticals CEO Robert Azelby to find out what the company is doing to address chronic migraine.

Alder Biopharma closes stock offering an...	03/05/19
No summary available.

Alder Biopharmaceuticals Inc (ALDR) CEO ...	02/26/19
No summary available.

Alder Biopharmaceuticals (ALDR) Investor...	01/08/19
No summary available.

Alder Biopharmaceuticals (ALDR) Investor...	01/08/19
No summary available.

ANALYST RATINGS

0 analyst ratings (Last 3 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $aldr

Service Name	Trader	% Success
Burdeshaw Investing	Matthew Burdeshaw	55.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.